Adequate regulation of glucose levels by a microencapsulated pancreatic islet graft requires a minute-tominute regulation of blood glucose. To design such a transplant, it is mandatory to have sufficient insight in factors influencing the kinetics of insulin secretion by encapsulated islets. The present study investigates factors influencing the glucose-induced insulin response of encapsulated islets in vitro. We applied static incubations and did the following observations. (i) Small islets (90-120 µm) showed a similar instead of a lower glucose-induced insulin response, suggesting that inclusion of only small islets, which are associated with lower protrusion and failing rates, has no consequences for the functional performance of the graft. (ii) A capsule diameter of 800 µm showed identical rather than lower glucose-induced insulin responses as smaller, 500-µm capsules. (iii) Capsule membranes constructed with a conventional permeability interfered with diffusion of insulin, as illustrated by a lower response of islets in capsules with a 10-min poly-L-lysine (PLL) membrane than islets in capsules with a 5-min PLL membrane. (iv) Irrespective of the tested porosity, the capsules provided sufficient immunoprotection because the 10-min PLL membranes did block diffusion of the cytokines IL-1β (17 kDa) and TNF-α (70 kDa) while the 5-min PLL membranes interfered with the diffusion of the vast majority of the cytokines. We conclude that capsules containing small islets (90-120 µm) and a membrane with a lower permeability than routinely applied is preferred in order to obtain a graft with adequate glucose-induced insulin responses.
INTRODUCTION
lated grafts (1, 8, 13, 21, 23) , it has been the focus of not more than a few studies (1, 6, 8, 11, 26) . The diffusion kinetics for encapsulated islets has been shown to be difImmunoprotection involves envelopment of tissue in a semipermeable membrane to protect donor cells against ferent from islets in the native pancreas. A delay in insulin response after a glucose stimulus has been observed antibodies and cytotoxic cells of the host immune system. This immunoprotection by encapsulation allows for both in vitro (33) and in vivo (1, 6, 11) . Plausibly, this delayed insulin response is caused by interference of the successful transplantation of cells in the absence of immunosuppression. A commonly used procedure for imcapsule membrane with optimal exchange of glucose and insulin (26). The rate of diffusion over the capsule munoprotection is microencapsulation of tissues in alginate-poly-L-lysine (PLL)-based capsules as originally membrane is determined by surface/volume ratio of the capsules. This implies that when the capsule diameter is described by Lim and Sun (19) . During recent years, important advances have been made with this technolsmall the ratio and thus the diffusion rate will be higher. Therefore, small capsule diameters are preferred for ogy. The first allotransplantations in humans with encapsulated parathyroid cells and pancreatic islets have been transplantation of encapsulated islets. Yet, a major obstacle in application of small-diameter capsules is the successfully performed (15,24). Also, successful xenotransplantation of islet grafts has been shown in both high amount of protruding islets, which cause rejection and subsequent failure of the graft (5, 7) . A conceivable chemically induced and autoimmune diabetic rodents (13,21,34), dogs (23, 32) , and monkeys (25, 38) .
approach to reduce protrusion is the use of only small islets for encapsulation. However, it is not known A major requirement for clinical application of encapsulated pancreatic islets is that the graft adequately whether this has a drawback on the function of the graft because small islets are assumed to produce less insulin regulates glucose levels. Although this is a factor that may contribute to the variable success rates of encapsuthan large islets.
In the present study we compare the glucose-induced verted into droplets using an air-driven droplet generator as previously described (37) . Subsequently, the alginate insulin response of encapsulated islets containing islets with different sizes. In addition, we identified some other droplets were transformed to alginate beads by gelling in a 100 mM CaCl 2 (10 mM HEPES, 2 mM KCl) solufactors influencing the glucose-induced insulin response of encapsulated pancreatic islets. Identification of such tion for at least 5 min (14). After gelation the beads had a diameter of 450-550 µm when 800-µm capsules were factors appears mandatory for modifying the alginate-PLL microencapsulation procedure in order to allow adproduced and 350-400 µm when 500-µm capsules were produced. The Ca-alginate beads were suspended for 3 equate responses of the microencapsulated tissue. min in KRH containing 2.5 mmol/L CaCl 2 . A PLL mem-
MATERIALS AND METHODS
brane was formed by suspending the alginate beads in Animals 0.1% PLL solution for 5 or 10 min (poly-L-lysine-HCl, MW: 22,000, Sigma). Nonbound PLL was removed by Male inbred Albino Oxford (AO/G) rats were obthree successive washings during 3 min with Ca
2+
-free tained from Harlan CPB (Zeist, The Netherlands) or the KRH containing135 mM NaCl. The outer alginate layer Central Animal Laboratory of Groningen. NHI guidewas subsequently applied by 5-min incubation in 10 lines for the care and use of laboratory animals were aptimes diluted alginate solution. plied.
Insulin Secretion During Glucose Challenge Islet Isolation
In static incubation experiments, islets were tested in Islets were isolated as previously described (36) .
four separate samples of 10 islets each. To minimize the Briefly, under ether anesthesia, the abdomen was opened variability of the mean insulin responses, we meticulously and the common bile duct was cannulated under nonselected islets with diameters between 90 and 120 µm. sterile conditions. The donor pancreas was distended
In some experiments we used other islet diameters, as with 10 ml sterile Krebs-Ringer-HEPES supplemented indicated in the Results section. The encapsulated islets with 25 mmol/L HEPES buffer (KRH) containing 10%
were preincubated for 45 min in 2 ml Krebs-Ringer-bicarbovine serum albumin (BSA). Subsequently, the panbonate (KRB), gassed with 95% O 2 and 5% CO 2 , containcreas was excised and brought into a laminar flow cabiing 0.25% BSA and 2.75 mM glucose. The quantitative net. All further procedures were performed under sterile insulin secretion was then assessed by three consecutive conditions. incubations of (i) 45 min in 2.75 mM glucose in KRB, The pancreas was chopped and digested using a two-(ii) 45 min in 16.5 mM glucose in KRB, and (iii) 45 min stage incubation of 20 min at 37°C with successively in 2.75 mM glucose in KRB. These incubations were 1.0 and 0.7 mg/ml collagenase (Sigma type XI, Sigma, performed in a Labline metabolic incubator at a stirring St. Louis, MO, USA). Islets were separated from exorate of 120 cycles/min at 37°C. At the end of each incucrine tissue by centrifugation over a discontinuous dexbation, the incubation media were removed and frozen tran gradient (30) and further purified by handpicking.
for insulin determination. The insulin secretory responses The diameters were measured with a dissection miwere expressed as nanogram of insulin ml −1 10 islets The incubations with varying experimental condimicrometer with an accuracy of 25 µm. For determinations were simultaneously performed with one batch of tion of the diameters we measured at least 150 islets.
islets on 1 day. These incubations were always performed Islets were cultured before encapsulation to reduce threefold to reduce variations in the individual expericontamination of the grafts with exocrine tissue, ducts, ments. The experiments were repeated five to eight times. or damaged cells. They were cultured in nontreated petri dishes (Greiner, Alphen a/d Rijn, The Netherlands) in
Cell Culture portions of 100 islets per 25 cm 2 for 19-44 h in RPMIThe nr8383 macrophage cell line was cultured in 60-1640 [containing 10% fetal calf serum (FCS, Gibco, ml culture flasks containing RPMI-1640 with 10% FCS, Breda, The Netherlands), 8.3 mmol/L glucose, 10 mmol/ 8.3 mmol/L glucose, 10 mmol/L HEPES, and 1% peni-L HEPES, and 1% penicillium/streptomycin] at 37°C in cillium/streptomycin. The cultures were kept at 37°C in humidified air containing 5% CO 2 .
humidified air containing 5% CO 2 .
Encapsulation
The nr8383 macrophage cell line was encapsulated in a novel two-step procedure. First, the cells were immoAfter culture, islets were washed three to five times with RPMI containing 10% FCS and were subsequently bilized in a small alginate bead of 200 µm. Therefore, LPS-stimulated (0.5 µg/ml for 1 h) nr8383 cells were suspended in sterile filtered (0.2 µm filtration) 3-3.3% purified alginate solution. The alginate solution was conmixed in a ratio of 30 million cells per 1 ml alginate.
FACTORS INFLUENCING INSULIN SECRETION FROM ENCAPSULATED ISLETS 619
The alginate/nr8383 suspension was converted into droptions tested showed identical instead of a size-dependent difference in their glucose-induced insulin response. The lets using an air-driven droplet generator (37) . Droplets of approximately 200 µm were produced and allowed to 210-300-µm islets produced slightly more insulin after stimulation with glucose, but this never reached statistigel for 5 min in 100 mM CaCl 2 (10 mM HEPES, 2 mM KCl). High numbers of cells were protruding from these cal significant difference. Surprisingly, the presence of a capsule around the issmall beads. In the second step, the cells containing Caalginate beads were resuspended in alginate for encapsulets reduced both the basal and the stimulated glucosereduced insulin response. Theoretically, this reduction in lation without protrusion of cells. To this end, the 200-µm Ca-alginate beads were suspended in a 2 ml 3.4% insulin response can be caused by two factors. First, the encapsulation procedure may have interfered with the alginate solution for a second envelopment in beads. The alginate containing immobilized nr8383 cells was conviability of the islet tissue because reportedly (14) some steps in the procedure interfere with adequate function verted into droplets and allowed to gel for 5 min in 100 mM CaCl 2 (10 mM HEPES, 2 mM KCl). After gelation of the islets. Secondly, and more plausibly, the presence of the capsule may have interfered with the exchange of the beads had a diameter of 550-600 µm. The beads were subsequently subjected to the encapsulation proceglucose and insulin over the capsule membrane (3, 8, 33) . To investigate whether the observed reduction in insulin dure as described in the encapsulation section.
To test the permeability of the capsules for the response was caused by a harmful step in the encapsulation procedure or by the presence of a capsule around nr8383-derived IL-1β and TNF-α, the beads were coated with three different PLL time periods to obtain three the islet we removed the capsule. To this end, the capsule was manually disrupted and removed before the indifferent permeabilities. Therefore, the beads were divided into three groups and incubated for 0, 5, and 10 sulin-secreting capacity of the so-called deencapsulated islets were tested. As shown in Figure 3 , the insulin remin with 0.1% PLL.
The experiments were always performed in triplicate sponse of deencapsulated islets was restored and statistically significantly higher (p < 0.02) than that of islets to reduce variations in the individual experiments. To this end, three separate samples of 100 capsules containstill enveloped within the capsules. Next, we investigated whether the interference of the ing macrophages were incubated in 24-well plates and cultured for 48 h in RPMI-1640 with 10% FCS, 8.3 capsule membrane with adequate glucose-induced insulin responses was caused by the relative large capsule mmol/L glucose, 10 mmol/L HEPES, and 1% penicillium/streptomycin at 37°C in humidified air containing size of 800 µm because the capsule size has been reported to be an important factor influencing the glucose-5% CO 2 . At the end of the experiments the incubation media were removed for assessment of IL-1β and TNFinduced insulin response of encapsulated islets (Fig. 4 ). Therefore, we tested and compared islets encapsulated α production. Data are expressed as ng/ml. in large (800-µm) capsules and islets encapsulated in Determinations small (500-µm) capsules. In these tests the capsules Insulin was determined by a radioimmunoassay for were incubated with 5 min of PLL instead of the 10 min rat insulin (Linco, St. Charles, MO, USA) using rat insuapplied in the experiments in Figure 2 . lin as a standard. IL-1β and TNF-α were determined by As shown in Figure 5 , the basal and stimulated in-ELISA (R&D, Abingdon, UK) using rat IL-1β and rat sulin secretion of islets in 500-and 800-µm capsules TNF-α as a standard.
showed similar if not identical insulin levels. Evidently, the reduction in capsule diameter from 800 to 500 µm Statistical Analysis did not bring about the expected increase in secretory Results are expressed as mean ± SEM. Statistical capacity of encapsulated islets. comparisons were made with the Mann-Whitney U-test.
A surprising observation in the previous experiment A value of p < 0.05 was considered statistically signifiwas done when we compared the quantitative insulin cant.
secretion of the encapsulated islets in the set of experiments in Figure 5 with those of the first set (Fig. 2) . In RESULTS the experiments presented in Figure 5 we found a basal and stimulated insulin secretion of encapsulated islets that The diameters of isolated islets varied between 60 and 300 µm (Fig. 1) . The effect of the islet diameter on was not lower but identical to that of free islets (106 ± 9 vs. 98 ± 11 for basal, and 308 ± 29 vs. 296 ± 42 for the insulin secretion before and after encapsulation was tested with diameter populations of 90-120, 150-180, stimulated). Because in the previous experiments we had set the incubation time with PLL to 5 min instead of the and of 210-300 µm because these islet diameters were present in sufficient numbers for static incubation testroutinely applied 10 min, we questioned whether the PLL incubation time was an unidentified factor detering. As shown in Figure 2 , the three diameter popula- mining the capacity of encapsulated islets to respond adwith 5-min PLL incubation could be explained by a lowered permeability of the capsules. Therefore, the effect equately to a glucose load.
Therefore, we tested and compared in a next set of of the PLL reaction time on the diffusion of low and high molecular molecules was investigated with the cyexperiments (i) free islets, (ii) islets in capsules treated for 5 min with PLL, and (ii) islets in capsules treated tokines IL-1β (17 kDa) and TNF-α (70 kDa). These permeability testings were done by assessing the diffusion for 10 min with PLL. As shown in Figure 6 , free islets and islets in capsules treated for 5 min with PLL elicited of these cytokines from encapsulated nr8383 macrophages. As shown in Figure 7 , we found that decreasing similar amounts of insulin during incubation in both low and high glucose while islets in capsules treated for 10 the conventional permeability of the membrane by reducing the PLL incubation time 5 min, the porosity of min with PLL showed a profound reduced response.
Finally, we questioned whether the improved results the membrane for IL-1β increased from <4% to 26%, and for TNF-α from <2% to 28%, illustrating a prothe islet diameters or capsule diameter in the routinely applied 500-800-µm range. found effect of this seemingly minor modification in PLL reaction time on the permeability of the capsules.
The finding that the glucose-induced insulin response of encapsulated islet is not influenced by the capsule's DISCUSSION diameter does not corroborate the findings of Chicheportiche et al. (3) . These authors observed an almost comTo provide a minute-to-minute regulation of blood glucose levels by transplanted microencapsulated islets, plete abrogation of the glucose-induced insulin response when the capsules size was increased from 300 to 800 the kinetics of insulin secretion by encapsulated islets are of crucial importance. This study clearly demonstrates µm. A possible explanation for this discrepancy in observations is the location of the islets in the capsules, that the responses of encapsulated islets are influenced by the permeability of the capsule membrane and not by which was more peripheral in the capsules applied in the present study (12) . This implies a shorter diffusion distance for both glucose and insulin over the capsule membrane and, therefore, may facilitate the responses of the islets in the large, 800-µm capsules. During our comparison of the glucose-induced insulin responses of islets with different sizes, we surprisingly found similar instead of size-dependent differences in insulin secretion. This lack of effect of islet size on insulin secretion could probably be explained by the fact that in isolated islets the glucose is penetrating the islets by passive diffusion instead of by active transport to each individual islet cell by the bloodstream. This passive diffusion of glucose is predictably less efficient than active transport to the islet cells by the bloodstream as in normal, vascularized islets in the native pancreas (2, 20) . Consequently, the glucose around large isolated islets will only stimulate islet cells in the periphery rather than the more centrally located islet cells. (4), who observed a similar insulin secretory response cal response but an adaptation of the basal insulin secretion to a continuous change in environment instead of in spite of a twofold difference in DNA content. However, our observations do not corroborate the findings of an increased response to a sudden change in metabolic demand. Also, the time period in which the challenge is Jahr et al. (16) and Reaven et al. (22) . This could be explained by a difference in the experimental set up.
performed may contribute to the difference in findings.
The magnitude of the response in static incubations is Jahr et al. studied the insulin secretion of islets only at a continuous high glucose level instead of investigating dependent on diffusion of glucose into the islets. This implies that this process is complete in a shorter period the responses during glucose challenge at low and a subsequent high glucose level (16). This is essential because of time in small than in large islets and may explain why in static incubation systems with short incubation the former does not necessarily represent the physiologi- Figure 6 . Effect of permeability of microcapsules on glucose-induced insulin response of microencapsulated rat islets. Free islets (n = 6, left), islets in capsules with low permeability induced by 5-min incubation in PLL (n = 6, middle), and islets in capsules with routine, commonly applied permeability by 10-min incubation in PLL (n = 6, right). Values represent mean ± SEM. periods small islets respond with a similar insulin secrethe glucose-induced insulin response by decreasing the PLL incubation time only 5 min is rather surprising, betion, because not all cells in the larger islets have participated. Consequently, when the incubations are performed cause our and other previous studies have shown that capsules treated with similar incubation times with simifor a longer period of time a higher response is to be expected. This argumentation is supported by the obserlar types of PLL molecules are permeable for substances up to 120 kDa (5, 17, 31) . Notably, previous studies on vations of Reaven et al. (22) , showing a somewhat higher response of the larger islets when the authors applied a permeability of capsules were performed with linear, nonionic molecules (mostly dextran), which have diffu-33% longer incubation period of 60 min instead of the conventional 45 min. In our experimental design we apsion characteristics far different from that of nonlinear and charged proteins such as insulin. Our present data plied a 45-min incubation period because in vivo, in successful graft recipients, glucose levels usually return to suggest that it is mandatory to study permeability of capsules by assessing the diffusion of relevant bioactive basal in this time period (9) .
The observation that encapsulated small, 90-120-µm factors rather than by measuring exchange of irrelevant model molecules such as dextran. islets show similar instead of lower glucose-induced insulin responses than 150-180-and 210-300-µm islets
The above also holds for diffusion of molecules that are involved in rejection of islets such as chemokines suggests that the inclusion of only small islets in encapsulated grafts will have no consequences for the funcand cytokines. Based on the molecular weight of the cytokines, it has been assumed that conventional immutional performance of the grafts. This is a pertinent consideration because small islets are associated with less noisolating capsules cannot prevent the entry of the majority of chemokines and cytokines (18) . In the present protrusion (5, 7, 27) and, therefore, a lower rate of failing encapsulated islets. Another advantage of application of study, we showed for the first time that in spite of their low molecular weight the cytokines IL-1β (17 kDa) and small islets is the reduction of problems associated with insufficient nutrition and central necrosis of the encapsu-TNF-α (70 kDa) cannot readily diffuse over the capsule membrane. Capsules membranes treated for 10 min with lated islets with sizes larger than 150 µm (10). This necrosis has been shown to be a major cause of failure PLL showed virtually no permeability for IL-1β and TNF-α while capsule membranes treated for 5 min alof encapsulated grafts (8, 10) . However, the effects of application of only the small rather than the large islets lowed passage of only a portion of less than 30% of the total amount of cytokines. After deencapsulating the on longevity of encapsulated islet grafts requires some further research considerations because longevity of the macrophages from the 5-and 10-min PLL-treated capsules, the cytokine levels reached the values of the nongraft is determined by the size of the graft volume (28, 29) , which is mainly determined by the number of treated PLL capsules (data not shown). This illustrates that the PLL treatment does not interfere with the cytolarge islets in the transplant (29, 35, 36) .
The dramatic effect of lowering the permeability on kine production by the macrophages but that the mem- 
